IL10 and hepatocellular carcinoma: M2-TAMs contribute to the formation of an immunosuppressive HCC microenvironment by the up-regulation of arginase 1 (ARG1) and IL-10, which leads to T cell depletion and NK cell inactivation [2,3], thus influencing the progression of HCC.